HAE - HAEMONETICS CORP

QQQ $ 463.74 $ 0.15 (0.03 %)

DIA $ 400.12 $ 2.30 (0.58 %)

SPY $ 543.85 $ 1.71 (0.32 %)

TLT $ 97.88 $ 0.61 (0.63 %)

GLD $ 226.19 $ -1.86 (-0.82 %)

Previous Close

$ 73.18

Open

Bid

$ 73.08 x 100

Ask

$ 73.21 x 100

Day's Range

-- - --

52 Week Range

$ 70.74 - $ 97.97

Volume

770,878

Average Volume

Market Cap

3.77B

Beta (5Y Monthly)

$ 0.80

PE Ratio (TTM)

$ 32.84

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-29-2024	10-Q
2	05-20-2024	03-30-2024	10-K
3	02-08-2024	12-30-2023	10-Q
4	11-02-2023	09-30-2023	10-Q
5	08-08-2023	07-01-2023	10-Q
6	05-22-2023	04-01-2023	10-K
7	02-07-2023	12-31-2022	10-Q
8	11-08-2022	10-01-2022	10-Q
9	08-10-2022	07-02-2022	10-Q
10	05-25-2022	04-02-2022	10-K
11	02-08-2022	01-01-2022	10-Q
12	11-09-2021	10-02-2021	10-Q
13	08-11-2021	07-03-2021	10-Q
14	05-26-2021	04-03-2021	10-K
15	02-02-2021	12-26-2020	10-Q
16	11-04-2020	09-26-2020	10-Q
17	08-04-2020	06-27-2020	10-Q
18	05-20-2020	03-28-2020	10-K
19	02-04-2020	12-28-2019	10-Q
20	11-01-2019	09-28-2019	10-Q
21	08-06-2019	06-29-2019	10-Q
22	05-22-2019	03-30-2019	10-K
23	02-05-2019	12-29-2018	10-Q
24	11-06-2018	09-29-2018	10-Q
25	08-07-2018	06-30-2018	10-Q
26	05-23-2018	03-31-2018	10-K
27	02-06-2018	12-30-2017	10-Q
28	11-07-2017	09-30-2017	10-Q
29	08-07-2017	07-01-2017	10-Q
30	05-24-2017	04-01-2017	10-K
31	02-06-2017	12-31-2016	10-Q
32	11-07-2016	10-01-2016	10-Q
33	08-01-2016	07-02-2016	10-Q
34	06-01-2016	04-02-2016	10-K
35	02-02-2016	12-26-2015	10-Q
36	11-04-2015	09-26-2015	10-Q
37	07-30-2015	06-27-2015	10-Q
38	05-22-2015	03-28-2015	10-K
39	02-05-2015	12-27-2014	10-Q
40	11-04-2014	09-27-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

JMP Securities Reiterates Market Outperfor...
08/13/2024 18:41:47

JMP Securities analyst David Turkaly reiterates Haemonetics (NYSE:HAE) with a Market Outperform and maintains $125 price tar...

Barrington Research Maintains Outperform o...
08/09/2024 21:46:20

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target f...

Haemonetics Reaffirms Fiscal 2025 Guidance...
08/08/2024 10:17:18

Haemonetics Q1 Adj $1.02 Beats $1.01 Estim...
08/08/2024 10:06:50

Haemonetics (NYSE:HAE) reported quarterly earnings of $1.02 per share which beat the analyst consensus estimate of $1.00 by 2 p...

Haemonetics Announced CE Mark Certificatio...
07/30/2024 10:11:33

The SavvyWire guidewire is the world's first and only sensor-guided 3-in-1 solution for Transcatheter Aortic Valve Implanta...

Haemonetics Announces A Limited Market Rel...
06/18/2024 20:17:02

haemonetics-strategic-moves-poised-to-boost-margins-and-earnings-says-analyst

Haemonetics' Strategic Moves Poised To Boo...
06/12/2024 17:34:28

Analyst upgrades Haemonetics to Buy, believes company can reach high-20% operating margin goal by FY26 through product mix anal...

this-mccormick-analyst-is-no-longer-bearish-here-are-top-5-upgrades-for-wednesday

This McCormick Analyst Is No Longer Bearis...
06/12/2024 13:45:38

Needham Upgrades Haemonetics to Buy, Annou...
06/12/2024 09:30:24

Needham analyst Mike Matson upgrades Haemonetics (NYSE:HAE) from Hold to Buy and announces $112 price target.

Haemonetics Prices Upsized Private Placeme...
05/23/2024 10:03:24

Haemonetics Announced $525M Convertible Se...
05/21/2024 20:41:06

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 20:31:00

4 Analysts Assess Haemonetics: What You Ne...
05/10/2024 17:01:10

JMP Securities Maintains Market Outperform...
05/10/2024 16:52:14

JMP Securities analyst David Turkaly maintains Haemonetics (NYSE:HAE) with a Market Outperform and raises the price target f...

Barrington Research Maintains Outperform o...
05/10/2024 14:30:02

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target f...

Needham Reiterates Hold on Haemonetics
05/10/2024 09:50:38

Needham analyst Mike Matson reiterates Haemonetics (NYSE:HAE) with a Hold.

Haemonetics Expects 2024 Revenue Growth Of...
05/09/2024 10:59:52

Haemonetics Expects 2024 Adjusted EPS Of $...
05/09/2024 10:58:40

Haemonetics Q4 2024 Adj EPS $0.90 Beats $0...
05/09/2024 10:10:57

Barrington Research Maintains Outperform o...
04/12/2024 14:43:30

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and maintains $105 price target.